Multidrug resistance, the principal mechanism by which many cancers develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapy. It affects patients ...
TAXIS Pharmaceuticals is developing first-in-class anti-resistance drugs to help re-engage widely prescribed but resistance-prone generic antibiotics to treat patients with multidrug-resistant ...
No writing assistance was utilized in the production of this manuscript. Gonorrhea burden and multidrug-resistance in N. gonorrhoeae remain major public health concerns that are poorly surveyed ...
Multidrug-resistant (MDR) A. baumannii is a rapidly emerging pathogen in healthcare settings, where it causes infections that include bacteremia, pneumonia, meningitis, and urinary tract and wound ...
The report highlights a complex landscape of progress and setbacks, noting that TB-related deaths fell slightly to 1.25 million in 2023, down from 1.32 million in 2022.